✓ Translated by DotMD AI Clinical Council Source: The Journal of clinical endocrinology and metabolism • Randomized Controlled Trial
Verify Primary Source: NIH PubMed PMID #10634364 ↗

Randomized Controlled Trial: Effects of hypogonadism and testosterone administration on depression indices in HIV-infected men (N = 52)

Original Paper Title: “Effects of hypogonadism and testosterone administration on depression indices in HIV-infected men”

Elena Rostova (AI Quant) Rigor Score
88 / 100
Sample Size (Participants)
N = 52
Evidence Classification
Randomized Controlled Trial
Sarah Jenkins, RN (AI Plain-English Editor) • Key Takeaways
  • This effect may be a direct effect of testosterone or related to positive effects of testosterone on weight and/or other anthropometric indices. Additional studies are needed to assess the effects of testosterone on clinical depression indices in human immunodeficiency virus-infected patients.
  • Study Design & Sample: Randomized Controlled Trial published in The Journal of clinical endocrinology and metabolism (N = 52 human participants).
  • Biostatistical Rigor Score: 88/100 audited by Elena Rostova (AI Biostatistician & openFDA Quant).

What the Study Found (In Plain English)

Published in The Journal of clinical endocrinology and metabolism (2000), this randomized controlled trial evaluating 52 human participants investigated: Hypogonadism is prevalent among human immunodeficiency virus-infected men, in whom significantly reduced quality of life and mood disturbances have been reported. Key clinical takeaway: This effect may be a direct effect of testosterone or related to positive effects of testosterone on weight and/or other anthropometric indices. Additional studies are needed to assess the effects of testosterone on clinical depression indices in human immunodeficiency virus-infected patients.

Dr. Lin (AI Evidence Lead): Statistical Endpoints & Numbers

Primary Endpoint & Quantitative Summary (The Journal of clinical endocrinology and metabolism, 2000-01-15; N = 52; Rigor 88/100): This effect may be a direct effect of testosterone or related to positive effects of testosterone on weight and/or other anthropometric indices. Additional studies are needed to assess the effects of testosterone on clinical depression indices in human immunodeficiency virus-infected patients.

Study Limitations & Caveats Before You Act

Clinical trials evaluate specific inclusion/exclusion cohorts under protocol-controlled conditions (Randomized Controlled Trial). Individual response, hepatic/renal clearance, CYP450 drug interactions, and baseline comorbidities vary; verify applicability with a board-certified physician before modifying any prescription or supplement regimen.

Related DotMD Clinical Hubs & Price Ledgers

Rx: testosterone-cypionate → Rx: testosterone → Condition: depression → Condition: patient-rights → Condition: erectile-dysfunction-following-radical-cystectomy →
Transparent AI Research Council • Grounded on NIH / FDA / PubMed Data

Ask our AI Specialists anything about PMID 10634364: Randomized Controlled Trial: Effects of hypogonadism and testosterone administration on depression indices in HIV-infected men (N = 52)

3 of 3 Free Questions Remaining